THOR MEDICAL ASA (TRMED.OL) Forecast, Price Target & Analyst Ratings

OSL:TRMED • NO0010597883

Current stock price

5.45 NOK
-0.13 (-2.33%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for THOR MEDICAL ASA (TRMED.OL).

Forecast Snapshot

Consensus Price Target

Price Target
NOK4.34
-20.46% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
40.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
NOK4.34
Upside
-20.46%
From current price of NOK5.45 to mean target of NOK4.34, Based on 8 analyst forecasts
Low
NOK3.54
Median
NOK4.34
High
NOK5.25

Price Target Revisions

1 Month
0.00%
3 Months
-15.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for TRMED.OL. The average price target is 4.34 NOK. This implies a price decrease of -20.46% is expected in the next year compared to the current price of 5.45.
The average price target has been revised downward by 15% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TRMED Current Analyst RatingTRMED Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

TRMED Historical Analyst RatingsTRMED Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
40.00%
TRMED.OL was analyzed by 8 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about TRMED.OL.
In the previous month the buy percentage consensus was at a similar level.
TRMED.OL was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
TRMED.OL revenue by date.TRMED.OL revenue by date.
N/A439K40.17M
9,050.34%		164.29M
308.99%		236.39M
43.89%
EBITDA
YoY % growth
TRMED.OL ebitda by date.TRMED.OL ebitda by date.
-6.484M
97.88%		N/A
-853.12%		-52.152M
15.61%		-38.625M
25.94%		-9.27M
76.00%		35.02M
477.78%
EBIT
YoY % growth
TRMED.OL ebit by date.TRMED.OL ebit by date.
-7.201M
97.72%		N/A
-829.73%		-73.076M
-9.15%		-71.585M
2.04%		-48.925M
31.65%		-3.09M
93.68%
Operating Margin
TRMED.OL operating margin by date.TRMED.OL operating margin by date.
N/AN/A-16,646.01%-178.21%-29.78%-1.31%
EPS
YoY % growth
TRMED.OL eps by date.TRMED.OL eps by date.
N/A
67.11%		N/A
50.51%		N/A
54.08%		-0.18
24.44%		-0.11
38.24%		-0.04
66.67%

All data in NOK

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in NOK

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TRMED.OL Yearly Revenue VS EstimatesTRMED.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2025 2026 2027 2028 50M 100M 150M 200M
TRMED.OL Yearly EPS VS EstimatesTRMED.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.64%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
385.95%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
36.67%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

THOR MEDICAL ASA / TRMED.OL Forecast FAQ

What do analysts expect the price target to be for THOR MEDICAL ASA (TRMED.OL)?

8 analysts have analysed TRMED.OL and the average price target is 4.34 NOK. This implies a price decrease of -20.46% is expected in the next year compared to the current price of 5.45.

How many analysts cover THOR MEDICAL ASA (TRMED.OL) stock?

The number of analysts covering THOR MEDICAL ASA (TRMED.OL) is 8.